Can surgeons improve survival in stage IV melanoma?

Paul J. Mosca, Erik Teicher, Suresh P. Nair, Barbara A. Pockaj

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


Successful systemic management of stage IV melanoma continues to be elusive because of the paucity of effective therapies. This has fueled the continued interest in surgical resection. Several single-institution studies and a current, large, multi-institutional phase III trial have demonstrated a survival benefit for patients who underwent surgical resection for melanoma metastases. Incorporating these results into new approaches using multimodality treatment may enhance survival in patients with stage IV melanoma.

Original languageEnglish (US)
Pages (from-to)462-468
Number of pages7
JournalJournal of Surgical Oncology
Issue number5
StatePublished - Apr 1 2008


  • Advanced disease
  • Immunotherapy
  • Metastasis
  • Surgery
  • Systemic therapy

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'Can surgeons improve survival in stage IV melanoma?'. Together they form a unique fingerprint.

Cite this